Related Experiment Video
Updated: May 21, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Data collaboration for causal inference from limited medical testing and medication data.
Tomoru Nakayama1, Yuji Kawamata2, Akihiro Toyoda1
1Graduate School of Science and Technology, University of Tsukuba, Tsukuba, Japan.
The data collaboration quasi-experiment (DC-QE) framework enables privacy-preserving causal inference using intermediate data representations. This approach enhances healthcare research by enabling access to larger datasets while protecting patient confidentiality.
Area of Science:
- Health Informatics
- Biostatistics
- Epidemiology
Background:
- Randomized controlled trials (RCTs) are not always feasible for causal inference.
- Integrating sensitive medical data across institutions poses significant privacy challenges.
- Existing methods often require sharing raw patient data, limiting collaborative research.
Purpose of the Study:
- To apply the data collaboration quasi-experiment (DC-QE) framework to medical data.
- To simulate distributed data environments under independent and identically distributed (IID) and non-IID conditions.
- To evaluate the efficacy of DC-QE for privacy-preserving causal inference in healthcare.
Main Methods:
- Developed a method for generating intermediate representations within the DC-QE framework.
- Applied DC-QE to single-institution medical data to simulate distributed settings.
- Compared DC-QE performance against individual and centralized analyses under IID and non-IID conditions.
Main Results:
- DC-QE consistently outperformed individual analyses across accuracy metrics.
- DC-QE performance closely approximated centralized analysis.
- The proposed method for intermediate representations improved performance, especially under non-IID conditions.
Conclusions:
- The DC-QE framework offers a robust method for privacy-preserving causal inference in healthcare.
- Utilizing intermediate representations facilitates access to larger, diverse datasets while maintaining patient confidentiality.
- This approach can advance the discovery of causal relationships, support drug repurposing, and improve rare disease therapies.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Causality in Epidemiology
Hazard Ratio
For example, in a clinical trial...
Statistical Software for Data Analysis and Clinical Trials
Comparing the Survival Analysis of Two or More Groups
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

